
BOTHELL, Wash., Dec. 1 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced that on November 20, 2009 it licensed to Chrono Nutraceuticals LLC exclusive rights in Canada to...
BOTHELL, Wash., Nov. 30 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced today that on November 25, 2009, the NYSE Amex LLC (the "Exchange") notified the Company that it...
BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (AMEX: DDD) today reported financial results for the three and nine months ended September 30, 2009. Stephen J. Turner, SCOLR...
BOTHELL, Wash., Sept. 18 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced today that on September 15, 2009, the NYSE Amex LLC (the "Exchange") accepted the Company's plan...
BOTHELL, Wash., Aug. 31 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) announced the appointment of Stephen J. Turner as Chief Executive Officer and President as of August 31...
BOTHELL, Wash., Aug. 7 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) today reported financial results for the three and six months ended June 30, 2009. Dr. Bruce Morra, SCOLR...
BOTHELL, Wash., May 1 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD) reported financial results for the three months ended March 31, 2009. The Company will host a live conference...
BOTHELL, Wash., April 29 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced plans to release first quarter 2009 financial results on Friday, May 1, 2009, at...
BOTHELL, Wash., April 2 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today announced the engagement of HealthPro BioVentures LLC ("HealthPro"), a life sciences...
BOTHELL, Wash., March 11 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Alternext US: DDD) today reported financial results for the three and twelve months ended December 31, 2008. The...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.56 | -25 | 2.24 | 2.45 | 1.37 | 112126 | 1.82905849 | CS |
4 | -1.22 | -42.0689655172 | 2.9 | 4.68 | 1.37 | 181927 | 3.05853801 | CS |
12 | 0.46 | 37.7049180328 | 1.22 | 4.68 | 1.22 | 72439 | 2.9824804 | CS |
26 | 1.23 | 273.333333333 | 0.45 | 4.68 | 0.45 | 61107 | 2.9104848 | CS |
52 | 1.23 | 273.333333333 | 0.45 | 4.68 | 0.45 | 61107 | 2.9104848 | CS |
156 | 1.23 | 273.333333333 | 0.45 | 4.68 | 0.45 | 61107 | 2.9104848 | CS |
260 | 1.23 | 273.333333333 | 0.45 | 4.68 | 0.45 | 61107 | 2.9104848 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales